Status:
RECRUITING
Genomic Sequencing in Anatomically Normal Fetuses
Lead Sponsor:
University of California, San Francisco
Conditions:
Pregnant Individuals Requesting Standard Microarray
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indication...
Detailed Description
Individuals who request prenatal diagnostic testing with standard chromosomal microarray will be offered GS as an option to assess for additional disease risk. The GS will be limited to evaluation of ...
Eligibility Criteria
Inclusion
- Pregnant patients who are:
- Pregnant with a structurally normal fetus (singleton or multiple gestation)
- Planning to undergo prenatal diagnosis by either chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine indications
- Planning, or have already completed expanded carrier screening
Exclusion
- Pregnant patients who:
- Decline prenatal diagnostic testing
- Are pregnant and their fetus has a known anomaly
- Declined chromosomal microarray analysis of expanded carrier screening
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06211348
Start Date
January 1 2024
End Date
January 1 2030
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143